JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1991) 128, 161-168       DOI: 10.1677/joe.0.1280161
© 1991 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H. S.
Right arrow Articles by Chard, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H. S.
Right arrow Articles by Chard, T.

Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy

H. S. Wang, L. A. Perry, J. Kanisius, R. K. Iles, J. M. P. Holly and T. Chard

Insulin-like growth factor-binding protein-1 (IGFBP-1) has been purified from amniotic fluid by anion exchange, hydrophobic interaction and gel filtration chromatography. The overall recovery of the purification process was 12·2%. The purified IGFBP-1 yielded a single band on SDS-PAGE gel but showed two bands (34 kDa and 68 kDa) on Western blot under non-reducing conditions. Polyclonal antisera were raised by immunization of sheep using the purified IGFBP-1. The best antiserum bound 50% of 125I-labelled IGFBP-1 at a final dilution of 1:500 000. A radioimmunoassay for IGFBP-1 was developed. This assay had a minimum detection limit of 5 µg/1, and was used to determine serum levels in non-pregnant and pregnant women. There was no cross-reaction with a wide variety of materials tested. Serum IGFBP-1 levels in non-pregnant individuals (33±16 (s.D.) µg/1) were found to be significantly lower than those in the second (96±64 µg/1) and third trimesters (95 ±60 µg/1) of pregnant women. During pregnancy, circulating IGFBP-1 levels increased rapidly in the first trimester and reached a peak at 12–13 weeks of gestation (107±75 µg/l). The level then remained at 80±53 to 103±70 µg/l until term.

Journal of Endocrinology (1991) 128, 161–168




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Y. H. Mak, J. J. Brosens, M. Christian, F. A. Hills, L. Chamley, L. Regan, and J. O. White
Regulated Expression of Signal Transducer and Activator of Transcription, Stat5, and its Enhancement of PRL Expression in Human Endometrial Stromal Cells in Vitro
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2581 - 2588.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Verhaeghe, A. Pintiaux, E. van Herck, G. Hennen, J.-M. Foidart, and A. Igout
Placental GH, IGF-I, IGF-Binding Protein-1, and Leptin during a Glucose Challenge Test in Pregnant Women: Relation with Maternal Body Weight, Glucose Tolerance, and Birth Weight
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2875 - 2882.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Ogilvy-Stuart, M. A. Soos, S. J. Hands, M. Y. Anthony, D. B. Dunger, and S. O'Rahilly
Hypoglycemia and Resistance to Ketoacidosis in a Subject without Functional Insulin Receptors
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3319 - 3326.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. Anim-Nyame, F.A. Hills, S.R. Sooranna, P.J. Steer, and M.R. Johnson
A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia
Hum. Reprod., October 1, 2000; 15(10): 2215 - 2219.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
R. P Holmes, J M P Holly, and P. W Soothill
Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 113F - 117.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
H.-S. Wang, T.-H. Wang, and Y.-K. Soong
Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy
Hum. Reprod., January 1, 2000; 15(1): 50 - 54.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Ogilvy-Stuart, S. J. Hands, C. J. Adcock, J. M. P. Holly, D. R. Matthews, V. Mohamed-Ali, J. S. Yudkin, A. R. Wilkinson, and D. B. Dunger
Insulin, Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1, Growth Hormone, and Feeding in the Newborn
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3550 - 3557.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. P. Miell, K. S. Langford, J. S. Jones, P. Noble, M. Westwood, A. White, and K. H. Nicolaides
The Maternal Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Response to Trisomic Pregnancy during the First Trimester: A Possible Diagnostic Tool for Trisomy 18 Pregnancies
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 287 - 292.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the Society for Endocrinology.